rs375075952
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 3P and 4B. PM1PP3BS2
The NM_000548.5(TSC2):c.5266G>A(p.Glu1756Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000868 in 1,612,638 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000548.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152142Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 250172Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135678
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1460496Hom.: 0 Cov.: 33 AF XY: 0.00000551 AC XY: 4AN XY: 726558
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152142Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74314
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
This variant is associated with the following publications: (PMID: 29778030, 29740858) -
- -
Hereditary cancer-predisposing syndrome Uncertain:1Benign:1
- -
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Tuberous sclerosis 2 Benign:2
- -
- -
Tuberous sclerosis syndrome Uncertain:1
This missense variant replaces glutamic acid with lysine at codon 1756 of the TSC2 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in two patients with a suspected diagnosis of tuberous sclerosis (PMID: 29778030, 29740858). This variant has been identified in 6/250172 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
TSC2-related disorder Uncertain:1
The TSC2 c.5266G>A variant is predicted to result in the amino acid substitution p.Glu1756Lys. This variant has been reported in individuals with clinical features consistent with tuberous sclerosis and in individuals with premature ovarian insufficiency (Zheng et al. 2018. PubMed ID: 29740858; Hesse et al. 2018. PubMed ID: 29778030; Xu et al. 2022. PubMed ID: 36229297). In vitro experimental studies showed conflicted functional evidence regarding its effect on protein function (Xu et al. 2022. PubMed ID: 36229297). This variant is reported in 0.0087% of alleles in individuals of Latino descent in gnomAD (v2), including 14 heterozygotes in the most recent release of gnomAD (v4, https://gnomad.broadinstitute.org/variant/16-2088452-G-A?dataset=gnomad_r4). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Lymphangiomyomatosis;C1846385:Isolated focal cortical dysplasia type II;C1860707:Tuberous sclerosis 2 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at